Documents

675 documents

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a document or publication you are looking for, such as press releases or speeches.
Sort by:
Subscribe to the latest documents
  1. How do I obtain an authorisation for my biocidal product in more than one Member State?

    For an authorisation of a biocidal product in more than one Member State, Biocidal Products Regulation 528/2012 provides the ...

    Frequently asked questions

  2. When is a product defined as a biocidal product?

    Biocidal Products Regulation 528/2012 defines biocidal products as follows: 'any substance or mixture, in the form in which it is ...

    Frequently asked questions

  3. Where can I find the list of active substance dossiers included in the review programme?

    Frequently asked questions

  4. Where do I find the list of approved suppliers? (BPR article 95 list)

    The list is published on the website of ECHA.

    Frequently asked questions

  5. What is a biocidal product?

    A biocidal product is a product with an active substance that is intended to destroy, deter, render harmless, prevent the action ...

    Frequently asked questions

  6. Where can I go with my questions about treated articles?

    The Ctgb no longer has a role in answering questions about treated articles. Questions about treated articles must be submitted ...

    Frequently asked questions

  7. Is my disinfectant product a biocidal product or a veterinary/medicinal product?

    Frequently asked questions

  8. What is the CTGB VAT-number?

    The Ctgb does not have a VAT-number.

    Frequently asked questions

  9. Will the fees and charges for applications be harmonised at the European level?

    At this time, harmonisation of fees and charges is not possible.

    Frequently asked questions

  10. When is a delivery and run-down period (grace period) granted?

    If changes with respect to a previous authorisation occur, for example if a scope of permitted use lapses, the formulation is ...

    Frequently asked questions